799 related articles for article (PubMed ID: 33182332)
1. Neuroprotective Effects of Safflower Flavonoid Extract in 6-Hydroxydopamine-Induced Model of Parkinson's Disease May Be Related to its Anti-Inflammatory Action.
Lei H; Ren R; Sun Y; Zhang K; Zhao X; Ablat N; Pu X
Molecules; 2020 Nov; 25(21):. PubMed ID: 33182332
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease.
Ren R; Shi C; Cao J; Sun Y; Zhao X; Guo Y; Wang C; Lei H; Jiang H; Ablat N; Xu J; Li W; Ma Y; Qi X; Ye M; Pu X; Han H
Sci Rep; 2016 Feb; 6():22135. PubMed ID: 26906725
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of a Standardized Flavonoid Extract from Safflower against a Rotenone-Induced Rat Model of Parkinson's Disease.
Ablat N; Lv D; Ren R; Xiaokaiti Y; Ma X; Zhao X; Sun Y; Lei H; Xu J; Ma Y; Qi X; Ye M; Xu F; Han H; Pu X
Molecules; 2016 Aug; 21(9):. PubMed ID: 27563865
[TBL] [Abstract][Full Text] [Related]
4. Preventive effects of a standardized flavonoid extract of safflower in rotenone-induced Parkinson's disease rat model.
Ablat N; Liu R; Ablimit M; Sun Y; Xu F; Zhao X; Han H; Pu X
Neuropharmacology; 2022 Oct; 217():109209. PubMed ID: 35940347
[TBL] [Abstract][Full Text] [Related]
5. Levodopa Improves Behavioral Deficits of Mice with Parkinson's Disease Symptoms via Curbing NLRP3 Inflammasome Activation and Enhancing Tyrosine Hydroxylase Levels in the Striatum and Substantia Nigra.
Chen X; Wang Z; Yang W; Fu Y
J Integr Neurosci; 2024 Jan; 23(1):2. PubMed ID: 38287845
[TBL] [Abstract][Full Text] [Related]
6. Effects of extracts and isolated compounds from safflower on some index of promoting blood circulation and regulating menstruation.
Yao D; Wang Z; Miao L; Wang L
J Ethnopharmacol; 2016 Sep; 191():264-272. PubMed ID: 27286914
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
8. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
[TBL] [Abstract][Full Text] [Related]
9. Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson's disease model via a β-arrestin2-biased mechanism.
Zhu J; Sun T; Zhang J; Liu Y; Wang D; Zhu H; Yao H; Ding J; Hu G; Lu M
Brain Behav Immun; 2020 Nov; 90():259-271. PubMed ID: 32861720
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson's disease induced by 6-OHDA.
Chan HH; Kumar S; Zhuo L
Eur J Pharmacol; 2013 Sep; 715(1-3):405-13. PubMed ID: 23652161
[TBL] [Abstract][Full Text] [Related]
11. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.
Xue YQ; Zhao LR; Guo WP; Duan WM
Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3.
Zhu J; Hu Z; Han X; Wang D; Jiang Q; Ding J; Xiao M; Wang C; Lu M; Hu G
Cell Death Differ; 2018 Nov; 25(11):2037-2049. PubMed ID: 29786071
[TBL] [Abstract][Full Text] [Related]
13. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
[TBL] [Abstract][Full Text] [Related]
14. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.
Jamali-Raeufy N; Mojarrab Z; Baluchnejadmojarad T; Roghani M; Fahanik-Babaei J; Goudarzi M
Metab Brain Dis; 2020 Mar; 35(3):539-548. PubMed ID: 32016817
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
[TBL] [Abstract][Full Text] [Related]
16. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
Kim HD; Jeong KH; Jung UJ; Kim SR
J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats.
Han B; Hu J; Shen J; Gao Y; Lu Y; Wang T
Eur J Pharmacol; 2013 Aug; 714(1-3):83-8. PubMed ID: 23791614
[TBL] [Abstract][Full Text] [Related]
18. Moutan Cortex Radicis inhibits the nigrostriatal damage in a 6-OHDA-induced Parkinson's disease model.
Choi YG; Hong YM; Kim LH; Yeo S; Lim S
Chin J Nat Med; 2018 Jul; 16(7):490-498. PubMed ID: 30080647
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.
Andringa G; van Oosten RV; Unger W; Hafmans TG; Veening J; Stoof JC; Cools AR
Eur J Neurosci; 2000 Aug; 12(8):3033-43. PubMed ID: 10971644
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease.
Ahmad M; Yousuf S; Khan MB; Ahmad AS; Saleem S; Hoda MN; Islam F
Hum Exp Toxicol; 2006 Jul; 25(7):361-8. PubMed ID: 16898164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
